Prophylactic antiviral therapy in CMV high-risk liver transplant recipients.
Rabkin
J M
JM
Department of Surgery, Section of Liver Transplantation, Oregon Health Sciences University and Portland Veterans Affairs Medical Center, Portland, Oregon, USA.
Rosen
H R
HR
Corless
C L
CL
Orloff
S L
SL
Olyaei
A J
AJ
D000212:Acyclovir / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous; D007275:Injections, Intravenous; D016031:Liver Transplantation / Q000276:immunology; D011446:Prospective Studies; D012306:Risk
D000998:Antiviral Agents; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin; D015774:Ganciclovir; D000212:Acyclovir